Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study

Abstract

Treatment with ACEI/ARB is associated with only a small increase in AKI risk while individual patient characteristics are much more strongly associated with the rate of AKI. The degree of increased risk varies between patient groups.